tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Hinge Health price target raised to $59 from $47 at Needham

Needham raised the firm’s price target on Hinge Health (HNGE) to $59 from $47 and keeps a Buy rating on the shares. The firm cites the Hinge’s strong first earnings print as a public company, as strong ROI, flexible pricing model and key payer/PBM relationships have created a value proposition that is resonating amongst benefits buyers in a rising healthcare cost environment, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1